Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Conceptus, Inc. (CPTS)
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Conceptus, Inc. (“CPTS” or the “Company”) (NASDAQ: CPTS) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Bayer HealthCare LLC, a subgroup of Bayer AG (OTC: BAYRY), in an all-cash deal valued at about $1.1 billion. Under the terms of the proposed transaction, Conceptus’ stockholders will receive $31.00 in cash for each share of Conceptus common stock they own. The proposed transaction is structured as a tender offer and may be effectuated without a shareholder vote.
The investigation focuses on whether Conceptus’ Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether and by how much this proposed transaction undervalues the Company to the detriment of Conceptus’ shareholders.
If you own common stock in Conceptus and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330.